Your browser doesn't support javascript.
loading
Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus.
Rani, Mridula; Bolles, Meagan; Donaldson, Eric F; Van Blarcom, Thomas; Baric, Ralph; Iverson, Brent; Georgiou, George.
Afiliación
  • Rani M; Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.
J Virol ; 86(17): 9113-21, 2012 Sep.
Article en En | MEDLINE | ID: mdl-22696652
Even though the effect of antibody affinity on neutralization potency is well documented, surprisingly, its impact on neutralization breadth and escape has not been systematically determined. Here, random mutagenesis and DNA shuffling of the single-chain variable fragment of the neutralizing antibody 80R followed by bacterial display screening using anchored periplasmic expression (APEx) were used to generate a number of higher-affinity variants of the severe acute respiratory syndrome coronavirus (SARS-CoV)-neutralizing antibody 80R with equilibrium dissociation constants (K(D)) as low as 37 pM, a >270-fold improvement relative to that of the parental 80R single-chain variable fragment (scFv). As expected, antigen affinity was shown to correlate directly with neutralization potency toward the icUrbani strain of SARS-CoV. Additionally, the highest-affinity antibody fragment displayed 10-fold-increased broad neutralization in vitro and completely protected against several SARS-CoV strains containing substitutions associated with antibody escape. Importantly, higher affinity also led to the suppression of viral escape mutants in vitro. Escape from the highest-affinity variant required reduced selective pressure and multiple substitutions in the binding epitope. Collectively, these results support the hypothesis that engineered antibodies with picomolar dissociation constants for a neutralizing epitope can confer escape-resistant protection.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Respiratorio Agudo Grave / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / Anticuerpos Neutralizantes / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Respiratorio Agudo Grave / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / Anticuerpos Neutralizantes / Anticuerpos Antivirales Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos